Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy

IntroductionPlasmacytoid dendritic cells (pDCs) are capable of triggering broad immune responses, yet, their scarcity in blood coupled to their reduced functionality in cancer, makes their therapeutic use for in situ activation or vaccination challenging. MethodsWe designed an in vitro differentiati...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Giovanna Fiore, Wolfgang Weckwarth, Kerstin Paetzold, Llucia Albertí Servera, Manuela Gies, Jakob Rosenhauer, Martina Antoniolli, Sina Nassiri, Stephan Schmeing, Steffen Dettling, Bhavesh Soni, Meher Majety, Anne B. Krug, Sabine Hoves, Monika Julia Wolf
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2024-11-01
Цуврал:	Frontiers in Immunology
Нөхцлүүд:	dendritic cell differentiation hematopoietic stem cells (HSCs) human DC vaccination cancer immunotherapy plasmacytoid dendritic cells (pDCs)
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1433119/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!